Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT01420874
Title Anti-CD3 x Anti-Erbitux Armed Activated T Cells (Phase Ib) for Gastrointestinal (GI Cancer)
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Barbara Ann Karmanos Cancer Institute
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Barbara Ann Karmanos Cancer Institute Detroit Michigan 48601 United States Details
*Shaded cells indicate that there was no data available from for the field